Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio Green Med Solution (BGMS) Cash & Current Investments (2016 - 2025)

Historic Cash & Current Investments for Bio Green Med Solution (BGMS) over the last 17 years, with Q3 2025 value amounting to $3.8 million.

  • Bio Green Med Solution's Cash & Current Investments rose 2793.33% to $3.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.8 million, marking a year-over-year increase of 2793.33%. This contributed to the annual value of $3.1 million for FY2024, which is 713.44% down from last year.
  • Latest data reveals that Bio Green Med Solution reported Cash & Current Investments of $3.8 million as of Q3 2025, which was up 2793.33% from $4.3 million recorded in Q2 2025.
  • In the past 5 years, Bio Green Med Solution's Cash & Current Investments registered a high of $47.8 million during Q1 2021, and its lowest value of $2.8 million during Q1 2024.
  • For the 5-year period, Bio Green Med Solution's Cash & Current Investments averaged around $17.7 million, with its median value being $10.2 million (2023).
  • Its Cash & Current Investments has fluctuated over the past 5 years, first skyrocketed by 43569.43% in 2021, then tumbled by 8524.38% in 2023.
  • Over the past 5 years, Bio Green Med Solution's Cash & Current Investments (Quarter) stood at $41.0 million in 2021, then plummeted by 44.21% to $22.9 million in 2022, then crashed by 85.24% to $3.4 million in 2023, then decreased by 7.13% to $3.1 million in 2024, then increased by 22.35% to $3.8 million in 2025.
  • Its Cash & Current Investments stands at $3.8 million for Q3 2025, versus $4.3 million for Q2 2025 and $3.5 million for Q1 2025.